DDIT4 and acute promyelocytic leukemia: In another report, the dysregulation of basal DDIT4 gene expression in several cancer types (e.g. lung, breast, prostate) can be altered by promyelocytic leukemia (PML) and lead to mTOR activation and cancer progression [37].